ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a commercial-stage immunotherapy company, today announced an exclusive U.S. Development and Supply Agreement wit

On May 15, 2026, Crane Co (CR) shares fell 4.1% to a current price of $172.19. This decline comes in the context of a 52-week range that saw a high of $214.31 a

Crane NXT NYSE: CXT reported first-quarter 2026 sales growth and reaffirmed its earnings outlook while updating its full-year guidance to include the recently completed acquisition of Antares Vision.

Completes Acquisition of Antares Vision, a Global Leader in Inspection, Detection, and Track & Trace Technologies Delivers Organic Sales Growth of 6%; Maintains Full Year EPS Guidance of $4.10 to $4.40 WALTHAM, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT) ("Crane NXT" or the "Company"), a global leader in authentication and traceability technologies, today announced its financial results for the first quarter ended March 31, 2026.

On May 01, 2026, Crane Co (CR) shares fell 3.1% to $172.24. This decline comes amid a 52-week trading range of $159.58 to $214.31, indicating some volatility in

Crane Company (CR) Q1 2026 Earnings Call Transcript

STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company ("Crane," NYSE:CR) today announced its financial results for the first quarter of 2026 and raised its full year adjusted EPS outlook. Alex Alcala, Crane's President and Chief Executive Officer, stated: "We delivered a very strong start to 2026, generating 15% adjusted EPS growth in the first quarter. Results exceeded our expectations with the majority of our outperformance driven by outstanding execution and momentum across our recent acquisitions.

STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE: CR) today announced the completion of its previously disclosed CEO succession plan, effective April 27, 2026. Mr. Alex Alcala has assumed the role of President and Chief Executive Officer, succeeding Mr. Max Mitchell, who has transitioned to the role of Executive Chairman, as planned. Mr. Alcala brings thirteen years of experience within Crane and deep knowledge of the Company's markets, operations, and strategic priorities. During his tenu.

Crane (NYSE: CR - Get Free Report) and EnWave (OTCMKTS:NWVCF - Get Free Report) are both industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends. Analyst Ratings This is a summary of current ratings and

State of Alaska Department of Revenue lowered its stake in shares of Crane (NYSE: CR) by 54.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,892 shares of the conglomerate's stock after selling 5,869 shares during the quarter.